Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $31,099 | 978 | 72.3% |
| Consulting Fee | $7,744 | 5 | 18.0% |
| Honoraria | $3,600 | 1 | 8.4% |
| Education | $542.02 | 9 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Galderma Laboratories, L.P. | $11,645 | 122 | $0 (2024) |
| ParaPRO, LLC | $3,600 | 1 | $0 (2024) |
| ABBVIE INC. | $2,411 | 72 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $2,369 | 49 | $0 (2024) |
| Promius Pharma LLC | $1,721 | 46 | $0 (2019) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $1,689 | 41 | $0 (2024) |
| Celgene Corporation | $1,459 | 14 | $0 (2019) |
| Janssen Biotech, Inc. | $1,270 | 57 | $0 (2024) |
| GENZYME CORPORATION | $1,213 | 19 | $0 (2024) |
| PFIZER INC. | $1,192 | 61 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $14,165 | 135 | Galderma Laboratories, L.P. ($6,691) |
| 2023 | $4,245 | 131 | Regeneron Healthcare Solutions, Inc. ($774.82) |
| 2022 | $3,072 | 105 | Sun Pharmaceutical Industries Inc. ($541.22) |
| 2021 | $3,595 | 136 | Galderma Laboratories, L.P. ($1,447) |
| 2020 | $2,006 | 74 | Galderma Laboratories, L.P. ($413.64) |
| 2019 | $3,631 | 131 | Galderma Laboratories, L.P. ($845.37) |
| 2018 | $5,597 | 162 | AbbVie, Inc. ($738.95) |
| 2017 | $6,675 | 119 | Aqua Pharmaceuticals ($1,093) |
All Payment Transactions
993 individual payment records from CMS Open Payments — Page 1 of 40
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $9.45 | General |
| Category: DERMATOLOGY | ||||||
| 12/19/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: Immunology | ||||||
| 12/18/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $6.97 | General |
| Category: DERMATOLOGY | ||||||
| 12/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $127.24 | General |
| Category: Immunology | ||||||
| 12/13/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $41.16 | General |
| Category: Dermatology | ||||||
| 12/12/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $120.90 | General |
| 12/12/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: Immunology | ||||||
| 12/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: Immunology | ||||||
| 12/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $110.71 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: Dermatology | ||||||
| 12/04/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $6.73 | General |
| Category: Immunology | ||||||
| 12/04/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $4.16 | General |
| Category: Dermatology | ||||||
| 11/23/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $30.49 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.20 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.29 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/13/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | Cabtreo (Drug), JUBLIA | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: Dermatology | ||||||
| 11/08/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: DERMATOLOGY | ||||||
| 11/07/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $151.20 | General |
| 10/29/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $30.88 | General |
| Category: IMMUNOLOGY | ||||||
| 10/26/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $146.47 | General |
| Category: Dermatology | ||||||
| 10/26/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $46.52 | General |
| Category: Inflammation | ||||||
| 10/26/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $46.52 | General |
| Category: Inflammation | ||||||
| 10/25/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $124.85 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 411 | 540 | $128,295 | $45,330 |
| 2022 | 12 | 741 | 969 | $141,664 | $65,257 |
| 2021 | 9 | 233 | 280 | $57,882 | $24,106 |
| 2020 | 2 | 43 | 50 | $9,500 | $4,028 |
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 97 | 152 | $30,350 | $12,027 | 39.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 68 | 68 | $25,425 | $9,709 | 38.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 56 | 79 | $23,650 | $8,911 | 37.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 37 | 53 | $15,900 | $5,233 | 32.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 55 | 55 | $16,300 | $4,961 | 30.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 22 | 24 | $6,000 | $1,990 | 33.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 20 | 26 | $5,200 | $1,274 | 24.5% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 18 | 23 | $2,990 | $1,090 | 36.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 14 | 16 | $1,600 | $100.28 | 6.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 24 | 44 | $880.00 | $36.14 | 4.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 152 | 184 | $25,311 | $14,024 | 55.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 106 | 120 | $25,863 | $12,414 | 48.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 78 | 86 | $17,366 | $8,032 | 46.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 80 | 80 | $18,136 | $7,630 | 42.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 45 | 45 | $14,547 | $6,213 | 42.7% |
| 96910 | Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | Office | 2022 | 13 | 42 | $10,500 | $4,943 | 47.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 51 | 56 | $10,851 | $4,542 | 41.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 89 | 97 | $10,972 | $4,100 | 37.4% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2022 | 30 | 34 | $3,704 | $1,511 | 40.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 18 | 19 | $1,648 | $921.24 | 55.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 49 | 165 | $2,201 | $891.91 | 40.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 30 | 41 | $564.08 | $36.32 | 6.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 50 | 71 | $10,650 | $6,004 | 56.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 29 | 36 | $9,000 | $4,399 | 48.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 39 | 39 | $9,750 | $3,693 | 37.9% |
About Dr. Sanjosh Singh, DO
Dr. Sanjosh Singh, DO is a Dermatology healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2007. The National Provider Identifier (NPI) number assigned to this provider is 1801086806.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sanjosh Singh, DO has received a total of $42,986 in payments from pharmaceutical and medical device companies, with $14,165 received in 2024. These payments were reported across 993 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($31,099).
As a Medicare-enrolled provider, Singh has provided services to 1,428 Medicare beneficiaries, totaling 1,839 services with total Medicare billing of $138,722. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Brooklyn, NY
- Active Since 07/26/2007
- Last Updated 11/09/2016
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1801086806
Products in Payments
- Natroba (Drug) $3,600
- DUPIXENT (Biological) $2,721
- Otezla (Drug) $2,319
- AKLIEF (Drug) $2,165
- EPIDUO FORTE (Drug) $1,724
- TREMFYA (Drug) $1,263
- EUCRISA (Drug) $1,184
- Humira (Biological) $1,046
- DORYX (Drug) $896.86
- VTAMA (Drug) $885.77
- CLODERM (Drug) $845.70
- Veltin (Drug) $786.00
- Cloderm Cream (Drug) $655.53
- SOOLANTRA (Drug) $619.56
- SILIQ (Drug) $589.11
- Sotyktu (Drug) $579.85
- SKYRIZI (Biological) $569.84
- Winlevi (Drug) $563.29
- DUPIXENT DUPILUMAB INJECTION (Biological) $543.64
- OPZELURA (Drug) $536.44
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Brooklyn
Dr. Hilary Baldwin, M.d, M.D
Dermatology — Payments: $1.6M
Dr. Steven Baranowitz, Md, MD
Dermatology — Payments: $1.3M
Dr. Susan Bard, M.d, M.D
Dermatology — Payments: $291,896
Amanda Doyle, M.d, M.D
Dermatology — Payments: $176,297
Dr. Michael Jackson, M.d, M.D
Dermatology — Payments: $153,050
Sourab Choudhury, Do, DO
Dermatology — Payments: $45,155